Sales for the IBO Analytical Instrument Index, which is comprised primarily of broad-based global analytical instrument businesses, declined 2.2% to $3,578 million. Excluding currency headwinds of 4.4%, Index sales grew 2.2%, driven by sales of LC and LC/MS, as well as demand from pharmaceutical and biopharma customers for Agilent and Waters. Demand for materials characterization […]
First quarter IBO Life Science Index sales advanced 6.3%, 7.1% excluding currency to $3,110 million, primarily due to Il-lumina’s strong sequencing revenues. Excluding Illumina, Index sales grew 2.7% or 2.8% on a currency-neutral basis. Overall, pharmaceutical and biopharma sales were strong for a majority of companies in the Index, especially for bioprouction within Thermo’s Life […]
First quarter US GDP was revised from an increase of 0.2% to a contraction of 0.7%. This divergence was attributed to a greater-than-expected trade imbalance as well as lower inventory growth and consumer spending. While early estimates suggest a rebound in second quarter GDP growth in the 3% range, weak consumer spending may constrain such […]
Growth for major publicly held instrument and laboratory product businesses stalled in the calendar year first quarter due to glaring currency headwinds and delayed government spending in Japan. For the seven US businesses whose financial results are profiled on page 9, sales contracted 1.8%, as currency and divestments reduced growth by 6.9% and 0.5%, respectively. […]
Expectations for industry growth showed little change compared to last fall (see IBO 10/15/14), according to IBO’s biannual Business Climate Survey. However, compared to a year ago, sentiments were more restrained. This spring, 57% of survey participants expect instrument and laboratory product–industry sales to increase moderately. Forty-three percent expect them to stay the same. However, […]
Danaher has done it again, announcing a major acquisition in the lab products market that will reshape the market. On May 11, the company unveiled its $13.8 billion planned acquisition of Pall to be followed next year by the spin off of Danaher’s more industrial companies into a separately traded public company (see page 2). […]
The Parenteral Drug Association’s Interphex (International Pharmaceutical Expo) show took place April 26–28 in New York City, New York, where it is held every year. The exhibit is dedicated to products for biopharmaceutical manufacturing. Attendance at the show rose 14% this year. Among the instrument companies exhibiting were Beckman Coulter Life Sciences, ChemoMetec, Freeslate, Hamilton, […]
IBO has moved up its quarterly financial review of major publicly held instrument and lab product businesses to the mid-month issues in order to provide more time-sensitive reporting. In addition, IBO has reorganized its Sales Indexes to one primary Laboratory Instruments and Products Sale Index, which will be presented in the May 31 issue. These […]
Improved economic conditions and stronger financial results elevated executive compensation in fiscal 2014 (FY14) as a majority of presidents and CEOs in IBO’s Laboratory Instruments and Products Stock Index (including Sigma-Aldrich) (Lab Index) recorded double-digit pay increases. For the 24 presidents and CEOs of companies in the Lab Index, who have served in their respective […]
The Life Science Sales Index article in the March 15 issue of IBO excluded a summary of Tecan results. For the second half of 2014, Tecan sales grew 10.2%, 5.8% organically, to CHF 227.5 million ($242.0 million = CHF 0.94 = $1). The acquisition of IBL (see IBO 7/31/14) contributed 4.5% to sales growth. Currency […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
